Table 4.
Clinical characteristics of the adult validation cohort used in STS proteomic analysis.
| Characteristic | AD FA+* | AD FA− | NA | p value |
|---|---|---|---|---|
|
Age (years) Mean (SD) |
33.0 (9.5) |
36.9 (11.9) |
41.0 (8.4) |
0.16 |
|
Gender, n(%) Female Male |
9 (75.0) 3 (25.0) |
11 (61.1) 7 (39.9) |
10 (76.9) 3 (24.1) |
0.57 |
|
Race, n(%) Caucasian Black or African American |
10 (83.3) 2 (16.6) |
16 (88.9) 2 (11.1) |
10 (76.9) 3 (24.1) |
0.67 |
|
EASI score Mean (SD) |
17.3 (10.8) |
16.4 (13.9) |
0.85 |
|
|
Total serum IgE, kU/L Mean (SD) |
1368 (1332) |
2475 (7373) |
35.6 (40.5) |
<0.0001 |
|
Total IgE to peanut, kUA/L Mean (SD) |
9.4 (14.9) |
4.4 (16.4) |
0.11 (0.03) |
<0.0001 |
*
Patients were defined as AD FA+ based on the history of clinical reactions to peanut.